| Igκ constant C/V28 region (Igk-C/Igk-V28)
|
0.12±0.03 |
1.00±0.01 |
0.23±0.00 |
| Ubiquitin carboxy-terminal hydrolase L1 (Uchl1)
|
0.23±0.01 |
1.00±0.03 |
0.27±0.03 |
| Ig joining chain (Igj)
|
0.15±0.02 |
1.00±0.08 |
0.31±0.02 |
| Ser/Cys peptidase inhibitor (Serpinb9b)
|
0.10±0.02 |
1.00±0.03 |
0.32±0.01 |
| Matrix metallopeptidase 3 (Mmp3)
|
0.10±0.00 |
1.00±0.00 |
0.35±0.01 |
| Lysosomal acid lipase A (Lipa)
|
0.18±0.02 |
1.00±0.07 |
0.36±0.01 |
| PRP19/PSO4 mammalian homolog (Prpf19)
|
0.28±0.01 |
1.00±0.03 |
0.36±0.01 |
| Alpha fetoprotein (Afp)
|
0.10±0.01 |
1.00±0.06 |
0.38±0.05 |
| Rock1 (Rock1)
|
0.46±0.04 |
1.00±0.08 |
0.40±0.01 |
| Thymus cell antigen 1ξ (Thy1)
|
0.33±0.01 |
1.00±0.03 |
0.40±0.03 |
| Isochorismatase domain containing 1 (Isoc1)
|
0.43±0.05 |
1.00±0.04 |
0.41±0.01 |
| Interferonγ (Ifng)
|
0.29±0.03 |
1.00±0.09 |
0.42±0.03 |
| Histone cluster 1H2a (Hist1h2a)
|
0.34±0.06 |
1.00±0.03 |
0.43±0.01 |
| Arylacetamide deacetylase-like 1 (Aadacl1)
|
0.19±0.01 |
1.00±0.02 |
0.44±0.02 |
| Glia maturation factorβ (Gmfb)
|
0.44±0.06 |
1.00±0.09 |
0.44±0.04 |
| BMP-binding endothelial regulator (Bmper)
|
0.42±0.01 |
1.00±0.03 |
0.44±0.03 |
| Vesicle-associated membrane protein B and C (Vapb)
|
0.34±0.00 |
1.00±0.05 |
0.46±0.00 |
| ADP-ribosylation factor-like 6 interacting protein 5 (Arl6ip5)
|
0.39±0.06 |
1.00±0.00 |
0.48±0.03 |
| IGF-2 mRNA binding protein 2 (Igf2bp2)
|
0.10±0.01 |
1.00±0.03 |
0.10±0.01 |
|
Genes that were downregulated in HFD and upregulated in Sal (blue dots in
Fig. 4D
)
|
|
Genes
|
NC
|
HFD
|
Sal
|
| Cut-like homeobox 1 (Cux1)
|
2.02±0.00 |
1.00±0.05 |
2.90±0.20 |
| Stat 3 (Stat3)
|
4.71±0.05 |
1.00±0.04 |
2.70±0.00 |
| Nischarin (Nisch)
|
4.08±0.48 |
1.00±0.07 |
2.66±0.06 |
| RAB43 (Rab43)
|
2.37±0.02 |
1.00±0.00 |
2.48±0.18 |
| Metastasis suppressor 1 (Mtss1)
|
4.47±0.65 |
1.00±0.02 |
2.27±0.04 |
